Estrogen Receptors and Melanoma: A Review.
estrogens
melanoma
woman
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
19 11 2019
19 11 2019
Historique:
received:
12
10
2019
revised:
14
11
2019
accepted:
16
11
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
8
7
2020
Statut:
epublish
Résumé
In the last three decades cutaneous melanoma has been widely investigated as a steroid hormone-sensitive cancer. Following this hypothesis, many epidemiological studies have investigated the relationship between estrogens and melanoma. No evidence to date has supported this association due to the great complexity of genetic, external and environmental factors underlying the development of this cancer. Molecular mechanisms through which estrogen and their receptor exert a role in melanoma genesis are still under investigation with new studies increasingly focusing on the discovery of new molecular targets for therapeutic treatments.
Identifiants
pubmed: 31752344
pii: cells8111463
doi: 10.3390/cells8111463
pmc: PMC6912660
pii:
doi:
Substances chimiques
Estrogens
0
Receptors, Estrogen
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Melanoma Res. 2002 Dec;12(6):529-38
pubmed: 12459642
Methods Mol Biol. 2016;1366:1-10
pubmed: 26585122
Am J Dermatopathol. 2014 Jan;36(1):74-9
pubmed: 23812018
Front Endocrinol (Lausanne). 2016 Oct 26;7:140
pubmed: 27833586
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1553-8
pubmed: 20080637
J Transl Med. 2016 Feb 24;14:56
pubmed: 26912358
J Mol Endocrinol. 2000 Feb;24(1):145-55
pubmed: 10657006
Fertil Steril. 2010 Feb;93(2):442-6
pubmed: 19394001
Cancer Res. 2005 Aug 15;65(16):7065-70
pubmed: 16103053
Hum Reprod. 2015 May;30(5):1216-28
pubmed: 25743782
Breast Cancer Res Treat. 2011 May;127(1):69-80
pubmed: 20535543
Cancer Med. 2017 Oct;6(10):2203-2212
pubmed: 28879661
Elife. 2018 Jan 16;7:
pubmed: 29336307
Med J Aust. 1985 Apr 15;142(8):446-8
pubmed: 3982348
Sci Rep. 2018 Aug 7;8(1):11805
pubmed: 30087366
Cancer Causes Control. 1992 May;3(3):199-205
pubmed: 1610966
Br J Cancer. 2002 Apr 8;86(7):1085-92
pubmed: 11953854
Clin Cancer Res. 2010 May 15;16(10):2702-8
pubmed: 20427689
J Steroid Biochem Mol Biol. 2014 Jan;139:245-51
pubmed: 23523517
Br J Cancer. 1985 Dec;52(6):901-7
pubmed: 4074642
Br J Cancer. 2019 Mar;120(6):621-632
pubmed: 30783203
Am J Epidemiol. 1995 May 15;141(10):943-50
pubmed: 7741124
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):236-246
pubmed: 27378491
Gastroenterology. 2009 Feb;136(2):683-93
pubmed: 19027010
J Cell Physiol. 2010 Jan;222(1):156-67
pubmed: 19780039
Curr Epidemiol Rep. 2019 Jun;6(2):112-118
pubmed: 32855900
Int J Womens Dermatol. 2017 Feb 16;3(1 Suppl):S11-S15
pubmed: 28492033
Mayo Clin Proc. 2012 Apr;87(4):328-34
pubmed: 22469345
Cancer Res. 2001 Mar 15;61(6):2537-41
pubmed: 11289127
J Clin Oncol. 2008 Feb 1;26(4):527-34
pubmed: 18235113
J Clin Oncol. 2012 Jun 20;30(18):2240-7
pubmed: 22547594
Fertil Steril. 2015 Oct;104(4):980-988
pubmed: 26232746
Int J Cancer. 2017 Nov 1;141(9):1763-1770
pubmed: 28685818
Melanoma Res. 2001 Oct;11(5):535-41
pubmed: 11595893
Mol Cell Biol. 2009 Jul;29(13):3783-90
pubmed: 19414598
Cell Mol Biol Lett. 2018 Jan 3;23:3
pubmed: 29308069
Cancer. 2003 Oct 1;98(7):1355-61
pubmed: 14508820
Cancer Prev Res (Phila). 2012 Jan;5(1):82-8
pubmed: 21933913
Int J Dermatol. 2010 Oct;49(10):1194-202
pubmed: 20883410
Am J Surg. 1998 Jun;175(6):437-44; discussion 444-5
pubmed: 9645769
Cancer Res. 2010 Jun 1;70(11):4778-84
pubmed: 20484043
Melanoma Res. 2013 Feb;23(1):70-8
pubmed: 23222548
J Natl Cancer Inst. 2010 May 19;102(10):706-21
pubmed: 20388878
J Endocrinol. 2010 Apr;205(1):15-23
pubmed: 20019181
J Clin Oncol. 2013 Jun 20;31(18):2337-46
pubmed: 23690423
Steroids. 2009 Aug;74(8):635-41
pubmed: 19463683
Cell Physiol Biochem. 2018;45(5):1878-1892
pubmed: 29510375
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S38-49
pubmed: 22018066
Cancer Causes Control. 1992 Nov;3(6):547-54
pubmed: 1420858
Oncogene. 2011 Mar 31;30(13):1542-50
pubmed: 21119596
Cancer Treat Rev. 2001 Aug;27(4):201-9
pubmed: 11545540
Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3673-E3681
pubmed: 29592953
Lancet. 2018 Sep 15;392(10151):971-984
pubmed: 30238891
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
Elife. 2016 Apr 26;5:
pubmed: 27115344
Exp Dermatol. 2006 Dec;15(12):971-80
pubmed: 17083364
Carcinogenesis. 2009 Apr;30(4):720
pubmed: 19168587
Cancer Causes Control. 2008 Jun;19(5):437-42
pubmed: 18197460
Br J Pharmacol. 2014 Feb;171(3):580-94
pubmed: 23981051
Br J Cancer. 2009 Jun 2;100(11):1824-31
pubmed: 19436296
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1453-1461
pubmed: 28467693
Br J Cancer. 1991 Mar;63(3):430-3
pubmed: 2003986
J Natl Cancer Inst. 1984 Mar;72(3):617-20
pubmed: 6583445
Eur J Cancer. 2011 Nov;47(17):2607-17
pubmed: 21620689
JAMA Dermatol. 2013 Aug;149(8):912-20
pubmed: 23804160
Lancet. 1995 Oct 14;346(8981):995-1000
pubmed: 7475593
Eur J Dermatol. 2017 Jun 1;27(3):254-259
pubmed: 28524047
Pigment Cell Melanoma Res. 2008 Aug;21(4):415-28
pubmed: 18582227
Br J Cancer. 1999 Aug;80(12):2025-33
pubmed: 10471056
Br J Cancer. 2015 Mar 31;112 Suppl 1:S129-36
pubmed: 25734396
Melanoma Res. 2011 Jun;21(3):244-52
pubmed: 21540649
Arch Dermatol. 2009 Jan;145(1):30-6
pubmed: 19153340
J Natl Cancer Inst. 1982 Apr;68(4):537-9
pubmed: 6951070
Br J Cancer. 1984 Nov;50(5):673-80
pubmed: 6498065
Nat Commun. 2014 Oct 03;5:5073
pubmed: 25278152
Int J Cancer. 1988 Dec 15;42(6):821-4
pubmed: 3192324
Cancer Res. 2009 Nov 1;69(21):8332-40
pubmed: 19826037
Breast Cancer Res Treat. 2011 Jun;127(2):417-27
pubmed: 20623183
Cancer. 2001 Mar 15;91(6):1148-55
pubmed: 11267960
J Am Coll Health. 2000 May;48(6):243-6
pubmed: 10863867
Hum Reprod. 2012 Apr;27(4):1149-55
pubmed: 22343550
Infection. 2015 Aug;43(4):399-403
pubmed: 25956991
Br J Cancer. 1981 Jul;44(1):45-50
pubmed: 7259960
Gene. 2018 Jun 5;658:28-35
pubmed: 29518546
J Clin Oncol. 2010 Sep 10;28(26):4038-44
pubmed: 20644089
Ann Surg. 2006 May;243(5):693-8; discussion 698-700
pubmed: 16633005
Br J Cancer. 1984 Nov;50(5):681-5
pubmed: 6498066
Obstet Gynecol. 2017 Jan;129(1):168-173
pubmed: 27926637
Int J Cancer. 2015 Aug 15;137(4):940-8
pubmed: 25650288
Mol Endocrinol. 2007 May;21(5):1132-47
pubmed: 17312270
Cancer. 2008 Apr 15;112(8):1795-804
pubmed: 18306371
Br J Cancer. 1996 May;73(9):1126-31
pubmed: 8624275
Expert Rev Anticancer Ther. 2008 Nov;8(11):1759-65
pubmed: 18983236
Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):661-8
pubmed: 7881339
J Clin Endocrinol Metab. 2016 Oct;101(10):3646-3656
pubmed: 27459534
Br J Cancer. 1977 Dec;36(6):804-9
pubmed: 597478
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):668-74
pubmed: 16150258
Chem Biol Interact. 2017 Nov 1;277:176-184
pubmed: 28947257
Cancer Res. 2009 Aug 1;69(15):6100-6
pubmed: 19602591
Steroids. 2008 Oct;73(11):1039-51
pubmed: 18501937
Br J Cancer. 2019 Apr;120(7):754-760
pubmed: 30814688
Int J Epidemiol. 1990 Sep;19(3):522-6
pubmed: 2262243
Genet Epigenet. 2016 Feb 24;8:1-6
pubmed: 26949342
Biochem Med (Zagreb). 2014 Oct 15;24(3):329-42
pubmed: 25351351
Eur J Cancer. 2009 Apr;45(6):1017-27
pubmed: 19109009
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):65-69
pubmed: 27231086